financetom
Business
financetom
/
Business
/
Accenture to Acquire Australia's Partners in Performance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Accenture to Acquire Australia's Partners in Performance
May 22, 2024 1:19 AM

03:55 AM EDT, 05/22/2024 (MT Newswires) -- Accenture ( ACN ) said late Tuesday it has agreed to acquire Australian consulting firm Partners in Performance.

The company did not disclose financial details of the transaction, which is subject to customary conditions including regulatory approvals.

Partners in Performance will enhance Accenture's ( ACN ) offering to clients in industries such as metals and mining, oil and gas, utilities and chemicals, with its roughly 400 employees joining Accenture Strategy, the company said.

Price: 303.31, Change: -0.33, Percent Change: -0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kremlin says it does not see any possibility to renew dialogue with Europe at the moment
Kremlin says it does not see any possibility to renew dialogue with Europe at the moment
Feb 24, 2025
MOSCOW, Feb 24 (Reuters) - Russia does not see any grounds to renew dialogue with Europe for now, Kremlin spokesman Dmitry Peskov said on Monday, hours after the EU agreed on a sixteenth package of sanctions against Russia over the conflict in Ukraine. ...
KKR's Bid to Acquire Perpetual Business Segments Rejected
KKR's Bid to Acquire Perpetual Business Segments Rejected
Feb 24, 2025
04:19 AM EST, 02/24/2025 (MT Newswires) -- KKR's (KKR) bid to acquire segments of Perpetual has been rejected, the Australian asset management company said Monday. Perpetual was considering an offer from KKR for its corporate-trust and wealth-management businesses but said it is now terminating the talks in accordance with the recommendations of an independent expert. Perpetual and KKR have engaged...
Takeda Secures EMA Approval for Additional Injection Option for Hereditary Angioedema Drug
Takeda Secures EMA Approval for Additional Injection Option for Hereditary Angioedema Drug
Feb 24, 2025
04:26 AM EST, 02/24/2025 (MT Newswires) -- Takeda Pharmaceutical Co ( TAK ) said Monday that the European Medicines Agency has approved an additional subcutaneous administration option for hereditary angioedema drug TAKHZYRO, or lanadelumab. The drug now comes in a 2 mL pre-filled pen for adolescent and adult patients, the company said. Hereditary angioedema is a rare genetic disease that...
Kosmos Energy's Q4 Swings to Adjusted Loss, Revenue Falls
Kosmos Energy's Q4 Swings to Adjusted Loss, Revenue Falls
Feb 24, 2025
04:00 AM EST, 02/24/2025 (MT Newswires) -- Kosmos Energy ( KOS ) reported a Q4 adjusted net loss Monday of $0.03 per diluted share, swinging from a profit of $ 0.31 a year earlier. Analysts polled by FactSet expected a breakeven. Revenue for the quarter ended Dec. 31 was $397.7 million compared with $507.8 million a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved